Peri Cruiser CAR-T: An innovative platform to reduce on-target off-tumor toxicity of CAR-T therapy

被引：0
|
作者：
Zhang, Shuangshuang [1 ]
Hao, Ruidong [1 ]
Wang, Hongye [1 ]
Yi, Qiao Yong [1 ]
Li Yantao [1 ]
Zhong, Yunpeng [1 ]
Sun, Minmin [1 ]
机构：
[1] Suzhou Immunofoco Biotechnol Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2539
引用
收藏
页数：1
相关论文
共 50 条
  • [21] AN NGS ASSAY TO IDENTIFY HLA LOSS OF HETEROZYGOSITY FOR FUTURE CEA AND MSLN LOGIC-GATED CAR-T SOLID TUMOR PROTOCOLS DESIGNED FOR REDUCED ON-TARGET, OFF-TUMOR TOXICITY
    Kopetz, Scott
    Morelli, Maria Pia
    Molina, Julian
    Simeone, Diane
    Hecht, J. Randolph
    Kirtane, Kedar
    Borad, Mitesh
    Welling, Theodore
    Garon, Edward
    Mardiros, Armen
    Wang, Xueyin
    Ng, Eric
    Danek, Tyler
    Gallagher, Shannon
    Lozac'hmeur, Ariane
    Beutner, Karl
    Welch, John
    Maloney, David
    Go, William
    Patel, Sandip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A83 - A83
  • [22] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Karan L. Chohan
    Elizabeth L. Siegler
    Saad S. Kenderian
    Current Hematologic Malignancy Reports, 2023, 18 : 9 - 18
  • [23] Switching CAR-T cells on and off
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2021, 20 (2) : 100 - 100
  • [24] NOVEL TARGET ANTIGENS FOR CAR-T CELL THERAPY
    Perriello, V. M.
    Falini, B.
    HAEMATOLOGICA, 2022, 107 : 11 - 12
  • [25] CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
    Bueno, Clara
    Velasco-Hernandez, Talia
    Gutierrez-Aguera, Francisco
    Zanetti, Samanta Romina
    Baroni, Matteo L.
    Sanchez-Martinez, Diego
    Molina, Oscar
    Closa, Adria
    Agraz-Doblas, Antonio
    Marin, Pedro
    Eyras, Eduardo
    Varela, Ignacio
    Menendez, Pablo
    LEUKEMIA, 2019, 33 (08) : 2090 - 2093
  • [26] CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
    Clara Bueno
    Talia Velasco-Hernandez
    Francisco Gutiérrez-Agüera
    Samanta Romina Zanetti
    Matteo L. Baroni
    Diego Sánchez-Martínez
    Oscar Molina
    Adria Closa
    Antonio Agraz-Doblás
    Pedro Marín
    Eduardo Eyras
    Ignacio Varela
    Pablo Menéndez
    Leukemia, 2019, 33 : 2090 - 2125
  • [27] Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion
    Shimizuguchi, T.
    Kanemasa, Y.
    Yagi, Y.
    Hayakawa, S.
    Taguchi, K.
    Ito, K.
    Murofushi, K.
    Sasaki, Y.
    Nakamura, S.
    Matsuda, S.
    Shimoyama, T.
    Toya, T.
    Shimizu, H.
    Najima, Y.
    Kobayashi, T.
    Doki, N.
    Haraguchi, K.
    Okuyama, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S207 - S207
  • [28] Research Progress of CAR-T Specific Therapy to Tumor
    Mei En-Dian
    Ma Jia-Bing
    Gao Jia-Dong
    Liu Yi-Xuan
    Qian Cheng
    Liu Li
    Wei Xu-Bin
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2019, 46 (04) : 333 - 341
  • [29] A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity
    Hammill, Joanne A.
    Kwiecien, Jacek M.
    Dvorkin-Gheva, Anna
    Lau, Vivian W. C.
    Baker, Christopher
    Wu, Ying
    Bezverbnaya, Ksenia
    Aarts, Craig
    Heslen, Christopher W.
    Denisova, Galina F.
    Derocher, Heather
    Milne, Katy
    Nelson, Brad H.
    Bramson, Jonathan L.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 278 - 292
  • [30] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
12345